Toxicological sciences : an official journal of the Society of Toxicology · 2005
Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kolb Todd M, Duan Ling, Davis Myrtle A
Аннотация
Although the precise role for the tuberous sclerosis complex-2 tumor suppressor gene (Tsc2) in tumor suppression is not clear, many studies have implicated Tsc2 in the regulation of cell differentiation, cell cycle control, GTPase activity, transcription, polycystin-1 localization, and translation initiation. We propose that Tsc2 also increases susceptibility to apoptosis, and that this functional role may contribute to the tumor suppressor activity of Tsc2. We previously characterized the apoptotic response of a Tsc2-null renal tumor cell line (ERC-18) to the tumor promoter okadaic acid (OKA). In the present study, we expressed Tsc2 in ERC-18 cells and compared the effect of Tsc2 expression on apoptotic induction. Tsc2 expression increased the susceptibility of ERC-18 cells to apoptosis induced by OKA and the phosphatidylinositol-3' kinase inhibitor, LY294002. In addition, Tsc2 expression abrogated OKA-induced cell detachment of ERC-18 cells. These results indicate that the OKA-induced, caspase-independent detachment previously observed in ERC-18 cells is Tsc2-dependent, and may support an additional role for the Tsc2 in regulating cell adhesion.
Предметные рубрики MeSH
AnimalsApoptosisCarcinoma, Renal CellCaspase 3CaspasesCell AdhesionCell Line, TumorCell ProliferationCell SurvivalChromonesDose-Response Relationship, DrugEnzyme InhibitorsGene Expression Regulation, NeoplasticKidney NeoplasmsMesothelinMorpholinesOkadaic AcidRatsTuberous Sclerosis Complex 2 ProteinTumor Suppressor Proteins